1. Regeneron Pharmaceuticals, Inc.
  2. Regeneron Pharmaceuticals, Inc. Ownership

Historical shareholding details of Lazard Asset Management LLC holdings in Regeneron Pharmaceuticals, Inc. (REGN)

Monthly changes of Lazard Asset Management LLC shareholding in Regeneron Pharmaceuticals, Inc. over the previous months

Month Name Total no. shares held Percent Holding
Feb 28, 2025 Lazard Asset Management Llc 6,058 0.01%
Jan 31, 2025 Lazard Asset Management Llc 6,081 0.01%
Dec 31, 2024 Lazard Asset Management Llc 19,912 0.02%
Dec 31, 2024 Lazard Asset Management Llc 6,081 0.01%
Nov 30, 2024 Lazard Asset Management Llc 5,039 0.00%
Oct 31, 2024 Lazard Asset Management Llc 5,039 0.00%
Sep 30, 2024 Lazard Asset Management Llc 16,216 0.01%
Sep 30, 2024 Lazard Asset Management Llc 4,931 0.00%
Aug 31, 2024 Lazard Asset Management Llc 5,573 0.01%
Jul 31, 2024 Lazard Asset Management Llc 5,573 0.01%
Jun 30, 2024 Lazard Asset Management Llc 16,450 0.01%
Jun 30, 2024 Lazard Asset Management Llc 5,580 0.01%
May 31, 2024 Lazard Asset Management Llc 4,659 0.00%
Apr 30, 2024 Lazard Asset Management Llc 4,445 0.00%
Mar 31, 2024 Lazard Asset Management Llc 16,309 0.01%
Mar 31, 2024 Lazard Asset Management Llc 4,445 0.00%
Feb 29, 2024 Lazard Asset Management Llc 3,708 0.00%
Jan 31, 2024 Lazard Asset Management Llc 3,708 0.00%
Dec 31, 2023 Lazard Asset Management Llc 10,682 0.01%
Dec 31, 2023 Lazard Asset Management Llc 3,851 0.00%
Nov 30, 2023 Lazard Asset Management Llc 3,856 0.00%
Oct 31, 2023 Lazard Asset Management Llc 3,856 0.00%
Sep 30, 2023 Lazard Asset Management Llc 11,056 0.01%
Sep 30, 2023 Lazard Asset Management Llc 4,068 0.00%
Aug 31, 2023 Lazard Asset Management Llc 4,068 0.00%
Jul 31, 2023 Lazard Asset Management Llc 4,069 0.00%
Jun 30, 2023 Lazard Asset Management Llc 11,156 0.01%
Jun 30, 2023 Lazard Asset Management Llc 4,602 0.00%
May 31, 2023 Lazard Asset Management Llc 4,605 0.00%
Mar 31, 2023 Lazard Asset Management Llc 14,353 0.01%
Dec 31, 2022 Lazard Asset Management Llc 14,176 0.01%

View all ownership details of Regeneron Pharmaceuticals, Inc.